Leuven-based Capricorn Partners has achieved the first close of its Capricorn Healthtech Fund II, raising €51 million to invest in transformative healthcare startups.
The fund aims to support innovation across digital health and medtech, improving personalized and value-based healthcare solutions throughout Europe.
Backing from Key Investors
The funding includes a €5 million investment from Amsterdam-based Invest-NL, alongside contributions from cornerstone investors like Quest for Growth, AG Insurance/Ageas Group, PMV, finance&invest.brussels, and KU Leuven Research & Development. Other participants include Sensinnovat and Centrum voor Ondersteuning van digitale Innovatie vzw (COI).
Mats Wassink, Investment Associate at Invest-NL, highlighted the fund’s importance:
“Capricorn Healthtech Fund II addresses the funding gap for companies too large for seed financing but too small for larger European funds. It also offers a robust network and over a decade of expertise in medtech and digital health.”
Advertisement
Focus and Investment Strategy
The fund will prioritize startups in the Benelux region and Europe, targeting innovative solutions that make healthcare more affordable and effective. Investments will range between €1M and €5M per company, focusing on late-seed to Series B-stage startups.
Capricorn Healthtech Fund II plans to back 10-15 companies working on solutions from traditional medical devices to advanced health software platforms.
Filip Pintelon, Investment Partner for Health at Capricorn, commented:
“With this fund, we aim to transform healthcare by integrating breakthrough innovations into mainstream practices, ensuring efficiency and accessibility.”
Long-Term Goals
Capricorn Partners is targeting a total fund size of €100 million and is actively engaging with additional investors to support this goal.
About Capricorn Partners
Founded in 1993, Capricorn Partners manages multiple venture capital and equity funds, focusing on European technology-driven companies. Its funds include the Capricorn Sustainable Chemistry Fund, Capricorn Digital Growth Fund, and others, supporting sectors like cleantech, biotech, and industrial innovation.
About Invest-NL
Founded in 2020, Invest-NL is dedicated to fostering sustainability and innovation in the Netherlands. The firm provides capital to visionary entrepreneurs and projects that drive societal and environmental impact, focusing on sectors like Life Sciences & Health.
With its first close, Capricorn Healthtech Fund II is set to empower healthcare innovators, advancing patient outcomes and making high-impact contributions to the European healthtech ecosystem.
